The era of digital innovation in scientific publication is here! Use all the tools in our toolbox to achieve maximum reach and impact. Look forward to exciting conversations! Join us if you can. whova.com/xems/apis/opengrap…
Representing my @Alphabet_Health team at a fundraiser golf outing for the @arcofessexnj , the fantastic organization which runs my brother's day program and group home! Thankful to have a boss and coworkers who care about my brother 🥰
Prelim top-line results from Pfizer mRNA vaccine trial in >40,000 randomized pts shows >90% efficacy in preventing new COVID infections with no reported major safety issues to date. Must wait detailed scrutiny of final results before celebrating but this is very promising.
Why has the United States handled this pandemic so badly? The Editors note that although we came into this crisis with enormous advantages, our current political leaders have demonstrated that they are dangerously incompetent.
Early high efficacy #DMT use resulted in less disability than those escalated to more effective treatments after an average of 5 years in 730 propensity-matched #MS patients in Italian Registry #MSVirtual2020
This study evaluated the metabolic effects of Roux-en-Y gastric bypass or diet alone in patients with diabetes who had lost matched amounts of weight. The primary outcome, the change in hepatic insulin sensitivity, was similar in the two groups.
"'You don’t look sick' is something that many people living with MS hear. Many of our symptoms are not visible for others to see and not every person experiences the same symptoms. It’s important to know that not every person with a disability looks the same." ~ Lina #ThisIsMS
Today is #WorldHepatitisDay
Hepatitis is one of the most common causes of liver cirrhosis and cancer.
We continue our work to increase testing and promote awareness of this viral disease in the EU and beyond.
Find out more: europa.eu/!Hv88MX
Follow: @ECDC_EU
For those of us living in New York City, a chart like this produces a lot of emotions and mixed thoughts. To say it's been a journey would be a massive understatement. Look forward to the next phase :) #NewYorkTough#COVID19@NYGovCuomo
This randomized, double-blind, placebo-controlled trial across the United States and parts of Canada showed no sign of benefit with #Hydroxychloroquine in preventing #Covid_19 infection. How many more studies do we need?
nejm.org/doi/full/10.1056/NE…
No surprises here, except that the trial was rushed, otherwise the 30% reduction in mortality might've had a chance to reach statistical significance. Regardless, the benefit was there and meaningful. #EvidenceBasedMedicine#Innovation#COVID19
In this double-blind RCT in 1063 adults hospitalized with #COVID19, a 10-day course of intravenous remidesivir was superior to placebo in shortening the time to recovery. The estimates of mortality at 14 days were 7.1% in the remdesivir group and 11.9% in the placebo group.